文献速递心脑血管急症重症综合管理与镇静镇痛

血管活性药物-正性肌力药物评分对ICU房颤相关血流动力学恶化患者28天死亡率的预测价值

[Predictive value of the Vasoactive Inotropic Score for 28-day mortality in patients with atrial fibrillation-related hemodynamic deterioration in the intensive care unit].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2026-01-01
一句话结论在ICU房颤相关血流动力学恶化患者中,VIS≥129.705是28天死亡的独立危险因素(OR=70.532),联合抗凝治疗预测AUC达0.938。

该回顾性队列研究纳入四川省人民医院重症医学科2020年9月至2025年5月收治的123例房颤相关血流动力学恶化ICU患者,其中28天内死亡68例、存活55例。ROC曲线分析显示VIS预测28天死亡的AUC为0.801(95%CI 0.722-0.880),最佳截断值为129.705(敏感度61.8%,特异度92.7%)。多因素logistic回归显示VIS≥129.705是28天死亡的独立危险因素(OR=70.532,95%CI 10.043-495.320),抗凝治疗为独立保护因素(OR=0.073,95%CI 0.006-0.870);联合抗凝与VIS≥129.705的预测模型AUC为0.938(95%CI 0.898-0.977),敏感度92.6%,特异度81.8%。

要点

  • VIS预测ICU房颤相关血流动力学恶化患者28天死亡:AUC 0.801(95%CI 0.722-0.880),最佳截断值129.705,敏感度61.8%,特异度92.7%。
  • VIS≥129.705是28天死亡的独立危险因素(OR=70.532,95%CI 10.043-495.320,P<0.001)。
  • 抗凝治疗是28天死亡的独立保护因素(OR=0.073,95%CI 0.006-0.870,P=0.038)。
  • 联合抗凝与VIS≥129.705的预测模型AUC为0.938(95%CI 0.898-0.977),敏感度92.6%,特异度81.8%。
  • 死亡组年龄更大,糖尿病、脓毒症、重症肺炎比例更高,CRRT使用更多,VIS、APACHE II、SOFA、CHA2DS2-VASc、HAS-BLED、WBC、CRP、PCT、乳酸更高,抗凝比例、HCO3-和MAP更低(均P<0.05)。

适用人群与场景

  • 纳入:2020年9月至2025年5月四川省人民医院重症医学科收治的、经持续心电监护记录回顾和专家裁定符合房颤相关血流动力学恶化定义的ICU患者,共123例。
  • 排除:原文未提及。
  • 场景:ICU。

诊断标准与关键阈值

  • 房颤相关血流动力学恶化:原文未给出具体定义标准,仅提及通过持续心电监护记录回顾和专家裁定识别。
  • VIS最佳截断值:129.705(用于预测28天死亡,敏感度61.8%,特异度92.7%,约登指数0.545)。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • VIS≥129.705提示28天死亡高风险(独立危险因素,OR=70.532),原文建议可作为床旁参考工具早期识别高危患者、进行风险分层和个体化治疗优化。
  • 未接受抗凝治疗与28天死亡风险升高相关(抗凝为独立保护因素,OR=0.073)。

研究设计与关键结果

  • 研究类型:回顾性队列研究;单中心(四川省人民医院重症医学科);样本量123例(死亡组68例,存活组55例)。
  • 主要终点:28天死亡率;VIS预测28天死亡的AUC为0.801(95%CI 0.722-0.880,P<0.001),最佳截断值129.705,敏感度61.8%,特异度92.7%,约登指数0.545。
  • 多因素logistic回归:VIS≥129.705是28天死亡的独立危险因素(OR=70.532,95%CI 10.043-495.320,P<0.001);抗凝治疗是独立保护因素(OR=0.073,95%CI 0.006-0.870,P=0.038);年龄、糖尿病史、心脏手术、CRRT与28天死亡率无显著关联(均P>0.05)。
  • 联合预测模型(抗凝+VIS≥129.705)预测28天死亡的AUC为0.938(95%CI 0.898-0.977,P<0.001),敏感度92.6%,特异度81.8%。
  • 单因素分析:死亡组较存活组年龄更大,糖尿病、脓毒症、重症肺炎比例更高,CRRT使用更多,心脏外科术后比例更低;VIS、APACHE II、SOFA、CHA2DS2-VASc、HAS-BLED、WBC、CRP、PCT、房颤发作时乳酸更高;抗凝治疗比例、房颤发作时HCO3-和MAP更低;总住院时间更短(均P<0.05)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(单中心)。
  • 证据等级或推荐强度:原文未提及。
  • 局限:单中心、回顾性设计、样本量较小(123例),VIS≥129.705的OR值95%CI宽(10.043-495.320),原文结论称联合模型可作为床旁参考工具,但需进一步验证。

对床旁实践的改变

  • 对于ICU房颤相关血流动力学恶化患者,可在房颤发作后48小时内计算VIS峰值,以129.705为参考阈值辅助识别28天死亡高危患者。
  • 原文提示抗凝治疗与28天死亡风险降低独立相关,但为回顾性观察性结果,不能据此直接改变抗凝启动决策;适用与不适用人群原文未明确。
  • VIS≥129.705联合抗凝状态的预测模型AUC为0.938,可作为床旁风险分层的参考工具,但原文为单中心回顾性研究,需前瞻性验证。
  • 常见陷阱:VIS截断值129.705及其OR值来自特定单中心队列,不宜直接外推为其他ICU人群的决策阈值;原文未提供VIS计算的具体药物剂量方案。

指南或共识出处

  • 原文未提及指南或共识出处;研究来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the predictive value of the Vasoactive Inotropic Score (VIS) for 28-day mortality in intensive care unit (ICU) patients with atrial fibrillation (AF)-related hemodynamic deterioration, to determine its optimal cutoff value, and to analyze its independent association with 28-day mortality risk.

METHODS: A retrospective cohort study was conducted. Patients with AF-related hemodynamic deterioration treated in the Department of Critical Care Medicine of Sichuan Provincial People's Hospital from September 2020 to May 2025 were enrolled. General clinical data, laboratory indices at ICU admission, arterial blood gas analysis and vital signs at AF onset, and the peak VIS within 48 hours of AF onset were collected through the electronic medical record system. According to the 28-day outcome, the patients were divided into a survivor group and a non-survivor group. Clinical data were compared between the two groups. Receiver operator characteristic curve (ROC curve) analysis was performed to evaluate the predictive value of VIS for 28-day mortality and to determine its optimal cutoff value. After stratifying patients by VIS using the optimal cut off value, variables with statistically significant differences in univariate analysis were entered into a multivariable logistic regression model to identify independent predictors of 28-day mortality. An ROC curve was further plotted to evaluate the predictive performance of the combined predictive model.

RESULTS: A total of 123 ICU patients who met the definition of AF-related hemodynamic deterioration were identified through retrospective review of continuous electrocardiographic monitoring records and expert adjudication. Among them, 68 died and 55 survived within 28 days. Univariate analysis showed that, compared with the survivor group, patients in the non-survivor group were older, had higher proportions of diabetes mellitus, sepsis, and severe pneumonia, were more likely to receive continuous renal replacement therapy (CRRT), and had a lower proportion of postoperative cardiac surgery patients. The levels of the VIS, Acute Physiology and Chronic Health Evaluation II(APACHE II), Sequential Organ Failure Assessment (SOFA), CHA2DS2-VASc score, HAS-BLED score, white blood cell count (WBC), C-reactive protein (CRP), procalcitonin (PCT), and lactic acid (Lac) at AF onset were higher in the non-survivor group than in the survivor group. In contrast, the proportion of patients receiving anticoagulation therapy, bicarbonate (HCO3-) levels at AF onset, and mean arterial pressure (MAP) at AF onset were lower, while the total length of hospital stay was shorter (all P<0.05). ROC curve analysis showed that VIS had good predictive performance for 28-day mortality, with an area under the curve (AUC) of 0.801 [95% confidence interval (95%CI) was 0.722-0.880, P<0.001]. When the optimal cutoff value of VIS was 129.705, the sensitivity was 61.8%, the specificity was 92.7%, and the Youden index was 0.545. Multivariable logistic regression analysis showed that VIS≥129.705 was an independent risk factor for 28-day mortality [odds ratio (OR)=70.532, 95%CI was 10.043-495.320, P<0.001], whereas anticoagulation therapy was an independent protective factor (OR=0.073, 95%CI was 0.006-0.870, P=0.038). Variables including age, history of diabetes mellitus, cardiac surgery, and CRRT were not significantly associated with 28-day mortality (all P>0.05). The combined prediction of anticoagulation and VIS≥129.705 achieved an AUC of 0.938 (95%CI was 0.898-0.977, P<0.001), with a sensitivity of 92.6% and a specificity of 81.8%, indicating good predictive performance.

CONCLUSIONS: VIS can effectively predict 28-day mortality in ICU patients with AF-related hemodynamic deterioration. The optimal cutoff value was 129.705, and VIS≥129.705 was an independent risk factor for 28-day mortality in this population. The combined predictive model based on VIS exhibited favorable predictive performance and may serve as a bedside reference tool for early identification of high-risk patients, facilitating clinical risk stratification and individualized therapeutic optimization.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Guo Z, Chang X, Qin X, et al. [Predictive value of the Vasoactive Inotropic Score for 28-day mortality in patients with atrial fibrillation-related hemodynamic deterioration in the intensive care unit]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42427324. doi:10.3760/cma.j.cn121430-20260108-00018

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。